Literature DB >> 17192644

Stoichiometry and pharmacology of two human alpha4beta2 nicotinic receptor types.

Mirko Moroni1, Isabel Bermudez.   

Abstract

The alpha4beta2 nicotinic acetylcholine receptor (nAChR) is the most abundant nAChR subtype in the brain, where it forms the high-affinity binding site for nicotine. The alpha4beta2 nAChR belongs to a gene family of ligand-gated ion channels that also includes muscle nAChRs, GABAA receptors, and glycine receptors and that assembles into pentameric structures. alpha4 and beta2 nAChR subunits expressed heterologously in Xenopus laevis oocytes assemble into a mixture of high- and low-affinity functional receptors, giving rise to biphasic ACh concentration-response curves (Zwart and Vijverberg, 1998; Buisson and Bertrand, 2001; Houlihan et al., 2001). High- and low-affinity alpha4beta2 nAChRs differ significantly in their functional and pharmacological properties (Zwart and Vijverberg, 1998; Buisson and Bertrand, 2001; Houlihan et al., 2001; Nelson et al., 2003) and result from the assembly of alpha4 and beta2 subunits into two distinct stoichiometric arrangements: (alpha4)2(beta2)3(high-affinity subtype) and (alpha4)3(beta2)2 (low-affinity subtype) (Nelson et al., 2003). In this study we have examined the functional and pharmacological properties of high- and low-affinity alpha4beta2 receptors using two-electrode voltage clamp procedures on Xenopus oocytes transfected with high (1:10) or low (10:1) ratios of alpha4/beta2 cDNAs, which yield high (1:10)- or low (10:1)- affinity receptors with monophasic ACh concentration- response curves. Furthermore, to determine the stoichiometry of high- and low-affinity receptors expressed heterologously by Xenopus oocytes, we have determined the stoichiometry of high- and low-affinity alpha4beta2 receptors by mutating a highly conserved hydrophobic residue in the middle (position 9') of the pore-lining domain, which increases agonist potency in a manner that allows predictions on subunit composition (Cooper et al., 1991; Revah et al., 1991; Labarca et al., 1995; Boorman et al., 2000).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17192644     DOI: 10.1385/JMN:30:1:95

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  8 in total

1.  Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor.

Authors:  E Cooper; S Couturier; M Ballivet
Journal:  Nature       Date:  1991-03-21       Impact factor: 49.962

2.  Four pharmacologically distinct subtypes of alpha4beta2 nicotinic acetylcholine receptor expressed in Xenopus laevis oocytes.

Authors:  R Zwart; H P Vijverberg
Journal:  Mol Pharmacol       Date:  1998-12       Impact factor: 4.436

3.  Chronic exposure to nicotine upregulates the human (alpha)4((beta)2 nicotinic acetylcholine receptor function.

Authors:  B Buisson; D Bertrand
Journal:  J Neurosci       Date:  2001-03-15       Impact factor: 6.167

4.  Activity of cytisine and its brominated isosteres on recombinant human alpha7, alpha4beta2 and alpha4beta4 nicotinic acetylcholine receptors.

Authors:  L M Houlihan; Y Slater; D L Guerra; J H Peng; Y P Kuo; R J Lukas; B K Cassels; I Bermudez
Journal:  J Neurochem       Date:  2001-09       Impact factor: 5.372

5.  Mutations in the channel domain alter desensitization of a neuronal nicotinic receptor.

Authors:  F Revah; D Bertrand; J L Galzi; A Devillers-Thiéry; C Mulle; N Hussy; S Bertrand; M Ballivet; J P Changeux
Journal:  Nature       Date:  1991-10-31       Impact factor: 49.962

6.  Stoichiometry of human recombinant neuronal nicotinic receptors containing the b3 subunit expressed in Xenopus oocytes.

Authors:  J P Boorman; P J Groot-Kormelink; L G Sivilotti
Journal:  J Physiol       Date:  2000-12-15       Impact factor: 5.182

7.  Alternate stoichiometries of alpha4beta2 nicotinic acetylcholine receptors.

Authors:  Mark E Nelson; Alexander Kuryatov; Catherine H Choi; Yan Zhou; Jon Lindstrom
Journal:  Mol Pharmacol       Date:  2003-02       Impact factor: 4.436

8.  Channel gating governed symmetrically by conserved leucine residues in the M2 domain of nicotinic receptors.

Authors:  C Labarca; M W Nowak; H Zhang; L Tang; P Deshpande; H A Lester
Journal:  Nature       Date:  1995-08-10       Impact factor: 49.962

  8 in total
  22 in total

1.  Allosteric modulation of alpha4beta2 nicotinic acetylcholine receptors by HEPES.

Authors:  Maegan M Weltzin; Yanzhou Huang; Marvin K Schulte
Journal:  Eur J Pharmacol       Date:  2012-06-23       Impact factor: 4.432

2.  Alpha-conotoxin AuIB isomers exhibit distinct inhibitory mechanisms and differential sensitivity to stoichiometry of alpha3beta4 nicotinic acetylcholine receptors.

Authors:  Anton A Grishin; Ching-I A Wang; Markus Muttenthaler; Paul F Alewood; Richard J Lewis; David J Adams
Journal:  J Biol Chem       Date:  2010-05-13       Impact factor: 5.157

3.  Identifying the binding site of novel methyllycaconitine (MLA) analogs at α4β2 nicotinic acetylcholine receptors.

Authors:  Gracia X J Quek; Diana Lin; Jill I Halliday; Nathan Absalom; Joseph I Ambrus; Andrew J Thompson; Martin Lochner; Sarah C R Lummis; Malcolm D McLeod; Mary Chebib
Journal:  ACS Chem Neurosci       Date:  2010-10-07       Impact factor: 4.418

4.  Quantitative Molecular Imaging of Neuronal Nicotinic Acetylcholine Receptors in the Human Brain with A-85380 Radiotracers.

Authors:  Shahrdad Lotfipour; Mark Mandelkern; Arthur L Brody
Journal:  Curr Med Imaging Rev       Date:  2011-05-01

5.  Nicotine Enhances the Hypnotic and Hypothermic Effects of Alcohol in the Mouse.

Authors:  Cassandra A Slater; Asti Jackson; Pretal P Muldoon; Anton Dawson; Megan O'Brien; Lindsey G Soll; Rehab Abdullah; F Ivy Carroll; Andrew R Tapper; Michael F Miles; Matthew L Banks; Jill C Bettinger; Imad M Damaj
Journal:  Alcohol Clin Exp Res       Date:  2016-01       Impact factor: 3.455

Review 6.  Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmission.

Authors:  R Exley; S J Cragg
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

Review 7.  Neuronal nicotinic receptors as novel targets for inflammation and neuroprotection: mechanistic considerations and clinical relevance.

Authors:  Merouane Bencherif
Journal:  Acta Pharmacol Sin       Date:  2009-06       Impact factor: 6.150

8.  An engineered glutamate-gated chloride (GluCl) channel for sensitive, consistent neuronal silencing by ivermectin.

Authors:  Shawnalea J Frazier; Bruce N Cohen; Henry A Lester
Journal:  J Biol Chem       Date:  2013-05-29       Impact factor: 5.157

9.  86Rb+ efflux mediated by alpha4beta2*-nicotinic acetylcholine receptors with high and low-sensitivity to stimulation by acetylcholine display similar agonist-induced desensitization.

Authors:  Michael J Marks; Natalie M Meinerz; Robert W B Brown; Allan C Collins
Journal:  Biochem Pharmacol       Date:  2010-06-30       Impact factor: 5.858

Review 10.  Nicotinic receptor channelopathies and epilepsy.

Authors:  Ortrud K Steinlein; Daniel Bertrand
Journal:  Pflugers Arch       Date:  2009-12-17       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.